Product Information
OXYBUTYNIN CL ER 10 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.0978 per EA under NDC 27241015608. Its NADAC has been published 375 times since Jun 19, 2019.
FDA first approved this application on Feb 28, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241015608
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211655FDA Approved
2/28/2019
TE Code
AB
On Market Since
2/28/2019
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 10 MG TABLET has been published 375 times since Jun 19, 2019, and over the history we have for it it has declined 77.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0978 per EA |
|---|---|
| All-time high | $0.4299 (Jul 10, 2019) |
| All-time low | $0.0837 (Nov 20, 2024) |
| 52-week high | $0.1089 |
| 52-week low | $0.0978 |
| Median price | $0.1231 |
| Average price | $0.1661 |
| Largest weekly change | +35.2% (Jun 19, 2024) |
| Weeks tracked | 375 |
| Tracking since | Jun 19, 2019 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 10 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.0978 per EA (NDC 27241015608), effective Aug 19, 2026.
How has the price of OXYBUTYNIN CL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has declined 77.2%. It has been tracked across 375 weekly CMS publications since Jun 19, 2019.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 10 MG TABLET?
Since Jun 19, 2019, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.4299 (Jul 10, 2019), with a median of $0.1231 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 10 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXYBUTYNIN CL ER 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXYBUTYNIN CL ER 10 MG TABLET?
OXYBUTYNIN CL ER 10 MG TABLET (NDC 27241015608) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.